What is the Prognosis for Alzheimers Disease?


Unfortunately, even with modern day medicine, the prognosis for Alzheimers disease is that it is an incurable, degenerative disease. However, according to recent studies there are variations in the prognosis of different patients. In fact, a patients symptoms are indicative of their prognosis.

Symptoms that May Indicate a Shorter Survival

There are certain symptoms that may indicate a person will have a shorter lifespan than other Alzheimers disease patients. Some of these indictors include: unsteadiness when walking; incontinence of urine; poor test scores on mental acuity tests; rapid decline during the first year they are diagnosed; wandering behaviors; and preexisting conditions such as heart disease or diabetes. Women also have a longer survival rate than men do when it comes to Alzheimers disease prognosis.

Treatments and Their Effects on Alzheimers Disease Prognosis

There are treatments for Alzheimers disease that may help those affected to retain their mental acuity longer. These treatments are generally seen as more effective when they are started at the earliest stages of the disease. Some treatments are relatively simple such as increasing the amount of time you walk per day. Other treatments may come in the form of medications. Whether or not a person is given certain medications or other treatments is dependent on their Alzheimers disease prognosis and its current stage. Treatment may also vary depending on the patient and their familys wishes.

There are several different medicines that can be used to combat Alzheimers disease. Two of these are Aricept and Namenda. Although these medications may not improve a persons long-term Alzheimers disease prognosis, they can improve the amount of time the person is able to stay reasonably mentally acute.

Aricept Aricept is one type of a cholinesterase inhibitor that is used in the treatment of Alzheimers disease. It is also the most common. This type of drug is used to stop the breakdown of cetylcholine. This is a chemical in the brain that is used for mental functions and plays a role in memory functions. Although this drug does not cure Alzheimers, it may help to improve mental acuity and function in some patients. This medication is used in all levels of Alzheimers disease including mild, moderate, and severe.

Namenda Namenda is a drug that works differently than other Alzheimer medications. It works to regulate a chemical called glutamate in the brain. This chemical regulates what other chemicals and minerals are allowed to enter brain cells. In a person with Alzheimers disease, their brains produce too much glutamate. By regulating this chemical, a person may have increased ability to process information and regulate memories.

American Alzheimer

Caring for someone with Alzheimers disease is not a simple task and each day can be filled with new challenges as the persons abilities change.

Theres no point in spending a ton of money on nutritional supplements for alzheimers disease if the supplements dont do what they claim to do. There can be incessant questions from your patient as to the time of day and numerous other sources of confusion that may seem quite simple and basic to you. At times, testing spinal fluid may be done as well. As you can see, these people really do have a difficult time planning and doing their daily activities. However, some promise is being seen in three drugs currently on the market, as well as in some herbs in treating some of the symptoms of the disease.

The tenth edition of the conference was not a small team of researchers, but comprised more than five thousand researchers who shared among them some pretty important information as well as resources on treating Alzheimers is it etiology, or pathology.
Mild forgetfulness is usually an early sign of Alzheimers, but this symptom does not mean that the disease is present. While Alzheimers disease history has shown the discovery of a degenerative illness that is as difficult for the patient as it is for the family members caring for him, there does seem to be hope on the horizon. With so much to take care of such as finances, pets and just plain living, children can bare most of the problems, besides the disease itself, when it comes to dealing with the illness for their parents. Thus, one way to address the difficult situation is to accept the problem and deal with it as best as one can. They may become unable to walk, sit-up by themselves and their muscles become rigid.

Many believe it is not a sign of remission of the disease, rather other portions of the brain or their pathways may be slowly accepting all of the work relegated to several areas that are no longer function.
The total points earned on the test is considered the patients position on the Alzheimers disease assessment scale and their level on a scale of one to seven, with one being very little sign of loss of cognitive ability and seven, meaning probable institutionalization. Yet another of the most significant facts about Alzheimers disease involves noticing the signs and symptoms. The tenth edition of the conference was not a small team of researchers, but comprised more than five thousand researchers who shared among them some pretty important information as well as resources on treating Alzheimers is it etiology, or pathology. These groups include late-onset Alzheimers disease and Familial Alzheimers Disease (FAD).